Digital Drug Development Services Provider Transparency Life Sciences Raises $5.0 Million in Series A Financing

New York, NY — February 15, 2018 — Transparency Life Sciences (TLS), a pioneer in digital drug development clinical services, today announced completion of a $5.0 million Series A financing led by venture investor New Ventures III. Existing private investors also participated. TLS will use the new financing to expand the company’s technology platform and […]